Physical Activity in Transfusion Dependent Patients With Myelodysplastic Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-10

Study Completion Date

2023-07-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy

NCT04103359

Myelodysplatic Syndromes

TERMINATED NA

Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.

NCT06645132

Blood Cancer Bone Marrow Transplant (BMT)

ACTIVE_NOT_RECRUITING NA

Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

NCT07140770

Physical Activity Sleep Allogenic Hematopoietic Cell Transplant

RECRUITING

Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant

NCT04985409

Multiple Myeloma Lymphoma Transplant-Related Disorder

COMPLETED NA

Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation

NCT02273024

Allogeneic Stem Cell Transplantation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study assesses feasibility and patient acceptability of using a Fitbit to monitor step count and heart rate in transfusion dependent patients with myelodysplastic syndrome. Information from this study may help researchers understand if there is any correlation between activity level and anemia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myelodysplastic Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational (activity monitor)

Patients wear an activity monitor (Fitbit) for 90 days. Patients also undergo collection of blood samples and complete questionnaires twice weekly for up to 90 days.

Medical Device Usage and Evaluation

Intervention Type OTHER

Wear activity monitor (Fitbit)

Biospecimen Collection

Intervention Type PROCEDURE

Undergo collection of blood samples

Questionnaire Administration

Intervention Type OTHER

Complete questionnaires

Quality-of-Life Assessment

Intervention Type OTHER

Complete questionnaires

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medical Device Usage and Evaluation

Wear activity monitor (Fitbit)

Intervention Type OTHER

Biospecimen Collection

Undergo collection of blood samples

Intervention Type PROCEDURE

Questionnaire Administration

Complete questionnaires

Intervention Type OTHER

Quality-of-Life Assessment

Complete questionnaires

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed pathologic diagnosis of MDS
* Requiring \>= 2 blood transfusions in the past month if previously diagnosed or hemoglobin =\< 8 g/dL if newly diagnosed
* Age \>= 18
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
* Ambulatory (use of a walking aid, such as a cane or rollator, is acceptable)
* Able to give informed consent
* Willing to comply with all study procedures and available for the duration of the study
* Able to read and/or understand English
* Have access to an iPhone 4S or later, iPad 3 generation or later, Android 5.0 or later, or Windows 10 device
* Have access to Bluetooth low energy (LE) and internet connection for syncing

Exclusion Criteria

• Uncontrolled illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No